biomedicina slovenica


"Farmakogenetika" : 67

  1. Goričar Katja
    ESHG Pharmacogenetics Course
    2022
  2. Tsermpini Evangelia Erini; Redenšek Sara; Dolžan Vita
    Genetic factors associated with tardive dyskinesia
    2022
  3. Redenšek Sara
    Farmakogenetika zdravljenja Parkinsonove bolezni
    2017
  4. Hernandez-Pacheco Natalia; Vijverberg Susanne J; Herrera-Luis Esther; Li Jiang; Sio Yang Yie; Granell Raquel; Corrales Almudena; Maroteau Cyrielle; Lethem Ryan; Perez-Garcia Javier; Repnik Katja; Gorenjak Mario; Berce Vojko; Potočnik Uroš
    Genome-wide association study of asthma exacerbations despite inhaled corticosteroids use
    2021
  5. Debeljak Jerneja; Korošec Peter; Lopert Anton; Fležar Matjaž; Košnik Mitja; Rijavec Matija
    Asthma treatment response to inhaled corticosteroids is associated with variants in VEGFA gene
    2021
  6. King Charlotte; McKenna Amanda; Farzan Niloufar; Vijverberg Susanne J; Schee Marc P. van der; Maitland-van der Zee Anke-Hilse; Arianto Lambang; Bisgaard Hans; B Klaus; Berce Vojko; Potočnik Uroš; Repnik Katja
    Pharmacogenomic associations of adverse drug reactions in asthma
    2020
  7. Prodan Žitnik Irena; Marc Janja; Dumić Jerka
    Cardiovascular diseases, immune system diseases, metabolic disorders
    2014
  8. Redenšek Sara; Jenko Bizjan Barbara; Trošt Maja; Dolžan Vita
    Clinical and clinical-pharmacogenetic models for prediction of the most common psychiatric complications due to dopamingeric treatment in Parkinson's disease
    2020
  9. Bertok Sara; Trebušak Podkrajšek Katarina; Rener-Primec Zvonka; Kržan Mojca; Pirtošek Zvezdan; Božič Borut
    Farmakogenetika protiepileptičnih zdravil pri otrocih in mladostnikih z epilepsijo
    2019
  10. Šmid Alenka; Jazbec Janez; Mlinarič-Raščan Irena
    Farmakogenetski označevalci v terapiji akutne limfoblastne levkemije pri otrocih
    [Pharmacogenetic markers in the therapy of childhood acute lymphoblastic leukemia]
    2019
  11. Just Katja S.; Turner Richard M.; Dolžan Vita; Cecchin Erika; Swen Jesse J.; Gurwitz David; Stingl Julia C.
    Educating the next generation of pharmacogenomics experts
    2019
  12. Redenšek Sara; Jenko Barbara; Trošt Maja; Dolžan Vita
    Clinical-pharmacogenetic predictive models for time to occurrence of levodopa related motor complications in Parkinson's disease
    2019
  13. Mazej Poredoš Barbara; Dolžan Vita
    Predpisovanje zdravil na podlagi genetskega testiranja bolnika - prihodnost je tukaj
    [Prescribing medicines after pharmacogenetic testing - the future is here]
    2019
  14. Iskra Vugdelija Lina; Kržan Mojca; Žiberna Lovro
    Osnovne značilnosti privzema dopamina v astrocite novorojene podgane
    2018
  15. Rijavec Matija; Žavbi Mateja; Lopert Anton; Fležar Matjaž; Korošec Peter
    GLCCI1 polymorphism rs37973 and asthma treatment response to inhaled corticosteroids
    2018
  16. Milek Miha; Šmid Alenka; Tamm Riin; Karas Kuželički Nataša; Metspalu Andres; Mlinarič-Raščan Irena
    Post-translational stabilization of thiopurine S-methyltransferase by S-adenosyl-L-methionine reveals regulation of TPMT*1 and *3C allozymes
    2012
  17. Jenko Barbara; Tomšič Matija; Jekić Biljana; Milić Vera; Dolžan Vita; Praprotnik Sonja
    Clinical pharmacogenetic models of treatment response to methotrexate monotherapy in Slovenian and Serbian rheumatoid arthritis patients
    2018
  18. Redenšek Sara; Dolžan Vita
    Pharmacogenetics of psoriasis treatment
    2017
  19. Rener-Primec Zvonka
    EPI-PGx - farmakogenetika zdravljenja z antiepileptiki pri otrocih
    2014
  20. Dolžan Vita
    Farmakogenetika v okviru projekta ARTEMIDA
    2015
  21. Dolžan Vita
    Farmakogenetika - kaj je dobro vedeti?
    2015
  22. Goričar Katja; Kovač Viljem; Dolžan Vita
    Clinical-pharmacogenetic models for personalized cancer treatment
    2017
  23. Fokter Dovnik Nina; Čavka Luka; Zakotnik Branko
    Farmakogenetika metotreksata pri osteosarkomu
    2016
  24. Berce Vojko; Homšak Matjaž; Tomazin Maja; Pinto Kozmus Carina; Potočnik Uroš
    Genetika in farmakogenomika astme ter vpliv gena ORMDL3 na učinek inhalacijskih kortikosteroidov
    [Genetics and pharmacogenomics of asthma and the influence of the ORMDL3 gene on the effect of inhaled corticosteroids]
    2013
  25. Jenko Barbara; Dolžan Vita; Praprotnik Sonja
    Klinično farmakogenetski modeli za bolniku prilagojeno zdravljenje revmatoidnega artritisa
    [Clinical pharmacogenetic models for personalized rheumatoid arthritis treatment]
    2016
  26. Turčin Arijana; Dolžan Vita; Porcelli Stefano; Serretti Alessandro; Kores-Plesničar Blanka
    Adenosine hypothesis of antipsychotic drugs revisited
    2016
  27. Milosheska Daniela; Lorber Bogdan; Vovk Tomaž; Kastelec Matej; Dolžan Vita; Grabnar Iztok
    Pharmacokinetics of lamotrigine and its metabolite N-2-glucuronide
    2016
  28. Novak Gregor; Šmid Lojze; Drobne David
    Pomen farmakogenetike in določanja koncentracij bioloških zdravil pri zdravljenju z zaviralci TNF-a pri kronični vnetni črevesni bolezni
    2015
  29. Dolinar Klemen; Pavlin Mojca; Chibalin Alexander V.; Pirkmajer Sergej
    Nucleosides blunt effects of AMPK activator AICAR in cultured skeletal muscle and cancer cells
    2016
  30. Redenšek Sara; Trošt Maja; Pirtošek Zvezdan; Dolžan Vita
    Pharmacogenetics of Parkinson's disease
    2016
  31. Redenšek Sara; Dolžan Vita
    Genetic determinants of Parkinson's disease
    2016
  32. Jenko Barbara; Tomšič Matija; Jekić Biljana; Milić Vera; Praprotnik Sonja; Dolžan Vita
    Clinical pharmacogenetic model or response to methotrexate monotherapy in Slovenian and Serbian rheumatoid arthritis patients
    2016
  33. Dolžan Vita; Goričar Katja
    Dear colleagues
    2016
  34. Brvar Miran
    Varna uporaba zdravil
    2016
  35. Klen Jasna; Dolžan Vita
    Pharmacogenetics of type 2 diabetes treatment
    2015
  36. Kores-Plesničar Blanka
    Personalized treatment of schizophrenia in everyday clinical practice
    2015
  37. Ostanek Barbara; Marc Janja
    Vloga farmakogenomike v posamezniku prilagojenem zdravljenju osteoporoze
    [The role of pharmacogenomics in personalised treatment of osteoporosis]
    2013
  38. Berce Vojko; Potočnik Uroš; Homšak Matjaž
    Pharmacogenetics of asthma in children - CTLA4 as a candidate gene
    2011
  39. Ostanek Barbara
    Genetika in farmakogenetika Gilbertovega sindroma
    [Genetics and pharmacogenetics of Gilbert's syndrome]
    2009
  40. Dolžan Vita; Jazbec Janez; Kralj Tina
    Kar - genetsko - smo, lahko vpliva na uspeh zdravljenja
    2013
  41. Dolžan Vita; Pirš Boštjan
    S svojim delom sem zadostila tako zdravniku kot naravoslovcu v sebi
    2014
  42. Potočnik Uroš; Koder Silvo; Ferkolj Ivan
    Pharmacogenomics of biological therapy against TNF-[alpha] in Crohn disease patients
    2011
  43. Berce Vojko; Perin Petra; Potočnik Uroš
    Pharmacogenomics of childhood asthma
    2011
  44. Goričar Katja; Dolžan Vita
    Farmakogenetski označevalci odgovora na zdravljenje z analogi folne kisline in spojinami platine pri osteosarkomu in malignem mezoteliomu
    [Pharmacogenetic markers of response to treatmant with folic acid analogues and platinum compounds in osteosarcoma and malignant mesothelioma]
    2014
  45. Poredoš Pavel
    Individualni pristop k predpisovanju zdravil
    2013
  46. Kovač Viljem
    Maligni mezoteliom - pojavnost v Sloveniji in pristopi k zdravljenju
    2013
  47. Krhin Blaž
    Molekularni označevalci pri Hurthlovem raku ščitnice
    2013
  48. Bešić Nikola
    Diagnostični izzivi pri redkih rakih ščitnice
    2013
  49. Ornik Vanja; Ferk Polonca
    Raznolikost v farmakološkem odzivu na zdravljenje z metforminom
    [Variability in pharmacological response to metformin treatment]
    2013
  50. Stamboldžioski Katja; Živec Aleš; Šivic Blaž; Obersnu Ita; Stamboldžioski Katja; Jošar Edith; Polič Vasilij; Štrukelj Borut; Marc Janja; Dolžan Vita; Blažič Jožef; Černelč Peter; Patrinos George P.; Rener-Primec Zvonka; Tomšič Matija; Milek Jožefa; Pajič Tadej; Kovač Viljem; Zorc Marjeta; Grabnar Iztok
    Zdravje Slovencev
    2013
  51. Lovrečić Luca
    Book of abstracts
    2013
  52. Klen Jasna; Janež Andrej; Dolžan Vita
    Sulfonylurea pharmacogenetics in type 2 diabetes
    2013
  53. Dolžan Vita; Lusa Lara
    Translating pharmacogenetics to clinical practice
    2013
  54. Faganel Barbara; Jazbec Janez; Dolžan Vita
    Vpliv genetske variabilnosti prenosa metotreksata na izid zdravljenja otrok z levkemijo
    [Influence of methotrexate transport genetic variability on treatment outcome in children with leukemia]
    2012
  55. Kores-Plesničar Blanka
    Farmakogenetika psihotropnih zdravil - uporaba v klinični praksi
    2012
  56. Dolžan Vita
    Kmalu pod lupo tudi učinkovitost bioloških zdravil: farmakogenetika bioloških zdravil za revmatoidni artritis
    2011
  57. Dolžan Vita; Štrukelj Borut
    Varfarin doslej edini primer: farmakogenetika v praksi
    2011
  58. Dolžan Vita
    Farmakogenetika v klinični praksi
    2007
  59. Mitrovič Mitja; Potočnik Uroš
    High resolution melting curve analysis for high-throughput SNP genotyping in IL23R gene and association of IL23R with Slovenian inflammatory bowel diseases patients
    2010
  60. Kastelic Matej
    Farmakogenetika antipsihotičnega zdravljenja shizofrenije: doktorsko delo
    [Pharmacogenetics of antipsychotic treatment in schizophrenia: doctoral thesis]
    2010
  61. Serretti Alessandro; Olgiati Paolo
    Pharmacogenetics of antidepressants
    [Farmakogenetika antidepresivov]
    2007
  62. Dolžan Vita
    Genetic polymorphisms and drug metabolism
    [Genetski polimorfizmi in presnova zdravil]
    2007
  63. Dolžan Vita
    Pharmacogenetics in clinical practice. Satellite meeting to the 15th international conference on cytochromes P450; 2007 Jun 22; Ljubljana
    [Farmakogenetika v klinični praksi. Satelitsko srečanje ob 15. mednarodni konferenci o citokromih P450; 2007 jun 22; Ljubljana]
    2007
  64. Videtič Alja
    Depresija in farmakogenetika monoaminskega sistema
    2007
  65. Stocco Gabriele; Martelossi Stefano; Decorti Giuliana; Ventura Alessando; Malusa Noelia; Bartoli Fiora; Giraldi Tullio
    Pharmacogenetics of thiopurines: can posology be guided by laboratory data?
    [Farmakogenetika tiopurinov: ali so laboratorijski podatki lahko odločilni v pozologiji?]
    2004
  66. Dolžan Vita; Kores-Plesničar Blanka
    Genetski polimorfizem CYP2D6 in ekstrapiramidni stranski učinki antipsihotičnih zdravil
    [CYP2D6 genetic polymorphism and extrapyramidal side effects of antipsychotic drugs]
    2002
  67. Dolžan Vita; Breskvar Katja
    Farmakogenetika v pediatriji
    2001



New search      Comments      Top of page Institute for Biostatistics and Medical Informatics